{"gene":"TBX2","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":2000,"finding":"TBX2 represses the Cdkn2a (p19ARF) promoter and attenuates E2F1, Myc, and HRAS-mediated induction of p19ARF, thereby bypassing cellular senescence and enabling immortalization.","method":"Genetic senescence bypass screen in Bmi1-deficient fibroblasts; promoter repression assays; transfection studies","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays, widely replicated across many subsequent studies","pmids":["11062467"],"is_preprint":false},{"year":2002,"finding":"TBX2 forms a complex with Nkx2.5 on the ANF promoter T-box binding element (TBE)-NK2 homeobox element (NKE) to cooperatively repress ANF gene expression in the atrioventricular canal myocardium.","method":"Transgenic analysis; in vivo mutagenesis of TBE and NKE elements; cotransfection/reporter assays; protein-protein interaction studies","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including in vivo transgenic validation and binding element mutagenesis","pmids":["12023302"],"is_preprint":false},{"year":2004,"finding":"Tbx2 is required to repress chamber myocardium-specific genes (Nppa, Cx40, Cx43, Chisel) in the atrioventricular canal; transgenic overexpression of Tbx2 in prechamber myocardium completely blocks chamber formation and suppresses chamber-specific gene expression.","method":"Targeted mutagenesis (Tbx2 null mice); transgenic overexpression; molecular analysis of marker gene expression","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function mouse models with defined molecular phenotype, corroborated by independent study (PMID:15459098)","pmids":["15042700","15459098"],"is_preprint":false},{"year":2002,"finding":"TBX2 and TBX3 specifically bind a variant T-site (13/20 nucleotide match to consensus) in the human p14ARF promoter to repress its transcription; both the core T-box DNA-binding domain and a C-terminal conserved repression domain are required for p14ARF repression.","method":"Mutant analysis of promoter T-site; deletion/domain mutagenesis; transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding and mutagenesis with functional reporter validation","pmids":["12000749"],"is_preprint":false},{"year":2004,"finding":"Tbx2 directly binds and represses the p21(WAF1) promoter in vitro and in vivo; siRNA-mediated knockdown of Tbx2 robustly activates p21 expression. Tbx2 targets histone deacetylase 1 (HDAC1) to the p21 initiator to mediate repression.","method":"In vitro DNA-binding assays; transfection reporter assays; chromatin immunoprecipitation (ChIP); siRNA knockdown; inducible dominant-negative Tbx2","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro binding with functional validation","pmids":["14996726","15781639"],"is_preprint":false},{"year":1998,"finding":"TBX2 acts as a transcriptional repressor by binding the MSEu and MSEi elements of the TRP-1 promoter; mutations in these elements that abolish TBX2 binding derepress TRP-1 promoter activity in melanocytes and melanoma cells. A high-affinity consensus Tbx2-binding site can constitutively repress a heterologous promoter.","method":"Electrophoretic mobility shift assays; cotransfection reporter assays; site-directed mutagenesis of promoter elements","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding combined with mutagenesis and functional reporter assays","pmids":["9710594"],"is_preprint":false},{"year":2000,"finding":"TBX2 binds a palindromic T-oligonucleotide as a monomer (unlike Xbra which binds as a dimer) and represses transcription from a chimeric reporter, whereas Xbra activates the same promoter, demonstrating distinct DNA-binding stoichiometry and transcriptional modulation properties.","method":"In vitro DNA binding assays; cotransfection reporter assays; antibody supershift assays","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical characterization with functional reporter validation","pmids":["11111039"],"is_preprint":false},{"year":2002,"finding":"Murine Tbx2 contains two transcriptional repression domains: a C-terminal domain conserved with Tbx3/ET, and a novel N-terminal domain (amino-terminal to the T-box); the T-box itself can weakly activate transcription in a promoter-context-dependent manner.","method":"Deletion analysis linked to GAL4 DNA-binding domain; cotransfection reporter assays","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — systematic deletion analysis with functional readout, single lab","pmids":["11867218"],"is_preprint":false},{"year":2000,"finding":"The Tbx2 promoter contains a full consensus Mitf (microphthalmia-associated transcription factor) recognition E-box element; Mitf binds the Tbx2 promoter in vitro and activates Tbx2 expression in vivo in an E-box-dependent manner, placing Tbx2 as a direct transcriptional target of Mitf in the melanocyte lineage.","method":"Promoter sequencing; in vitro binding (EMSA); in vivo transfection; E-box mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding confirmed with in vivo activation and mutagenesis","pmids":["10770922"],"is_preprint":false},{"year":2000,"finding":"BMP2 signaling induces Tbx2 (and Tbx3) expression in non-cardiogenic embryonic tissue; the BMP antagonist Noggin downregulates Tbx2 gene activity; Tbx2 expression is absent in bmp2 null mouse embryos, placing Tbx2 downstream of BMP2 signaling in early cardiogenesis.","method":"BMP2 bead application to chick embryos; Noggin treatment; analysis of bmp2 null mouse embryos","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function (bead application), loss-of-function (Noggin, knockout mouse), replicated in multiple systems","pmids":["11087629"],"is_preprint":false},{"year":2006,"finding":"Tbx2 protein levels are cell-cycle regulated: low in G1, rising through S-phase, persisting through G2, then dramatically reduced at mitosis onset. In S-phase, Tbx2 localizes to a subset of late replication foci and to small subnuclear DNA-associated foci distinct from telomeres, PML or Cajal bodies.","method":"Cell cycle synchronization; Western blotting; immunofluorescence; colocalization studies","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional context, single lab","pmids":["16730707"],"is_preprint":false},{"year":2007,"finding":"UV irradiation induces p38 MAPK-mediated phosphorylation of Tbx2 at serine residues 336, 623, and 675; this phosphorylation increases Tbx2 protein levels, drives nuclear localization, and enhances Tbx2-mediated repression of the p21 promoter.","method":"In vitro kinase assays; site-directed mutagenesis; Western blotting; immunofluorescence; reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay with mutagenesis of specific phospho-sites and functional reporter validation","pmids":["18025091"],"is_preprint":false},{"year":2010,"finding":"Tbx2 specifically associates with active hypophosphorylated retinoblastoma protein (Rb1), but not with p107 or p130; this interaction maps to a domain carboxy-terminal to the T-box, enhances Tbx2 DNA binding and transcriptional repression, and modulates Tbx2 target gene selectivity including cell cycle control genes.","method":"Co-immunoprecipitation; domain mapping; microarray analysis; inducible dominant-negative Tbx2 with Rb1-interaction domain mutation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction mapping, domain mutagenesis, and genome-wide target analysis in a single study","pmids":["20534814"],"is_preprint":false},{"year":2009,"finding":"Tbx20 directly attenuates BMP/Smad-dependent transcriptional activation of Tbx2 by binding Smad1 and Smad5 and sequestering them from Smad4, independently of Tbx20 DNA binding. A BMP/Smad-dependent Tbx2 enhancer confers AVC-restricted expression and Tbx20-dependent chamber suppression of Tbx2.","method":"Single and double knockout embryo analysis; identification of Tbx2 enhancer; transfection and localization studies; Smad binding assays","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis combined with biochemical interaction studies and enhancer identification","pmids":["19661464"],"is_preprint":false},{"year":2011,"finding":"Tbx2 and Tbx3 function redundantly to maintain AVC myocardium phenotype; ChIP-sequencing of Tbx3 reveals direct interaction with and repression of chamber myocardial genes; Tbx2/3 trigger atrioventricular cushion development through a regulatory feed-forward loop with Bmp2.","method":"Knockout and inducible overexpression mouse models; expression profiling; ChIP-sequencing","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq with genetic knockout models, multiple orthogonal approaches","pmids":["22130515"],"is_preprint":false},{"year":2013,"finding":"Tbx2 directly binds to the Cdkn1a (p21) and Cdkn1b (p27) loci in vivo in lung mesenchyme (ChIP); loss of Tbx2 causes lung hypoplasia with increased p21/p27 expression, and combined deletion of Cdkn1a and Cdkn1b largely rescues the lung growth deficit of Tbx2-deficient mice.","method":"Conditional knockout mice; genetic rescue (double Cdkn1a/Cdkn1b knockout); ChIP; gene expression analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP demonstrates direct binding, genetic epistasis rescue confirms functional relevance","pmids":["23341776"],"is_preprint":false},{"year":2013,"finding":"Tbx2 directly represses Grem1 in the posterior limb mesenchyme (by binding T-box elements in the Grem1 locus), thereby terminating the Shh/Fgf4 signaling loop; Tbx2-deficient hindlimbs show prolonged Shh/Fgf4 signaling and digit duplication, while overexpression causes premature loop termination.","method":"Tbx2 conditional knockout and overexpression in mice; ChIP; in vivo reporter assays; digit phenotype analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — direct binding shown by ChIP, confirmed by reciprocal loss- and gain-of-function phenotypes","pmids":["23633963"],"is_preprint":false},{"year":2016,"finding":"Tbx2 and Tbx3 act downstream of epithelially derived Shh signaling in lung mesenchyme to maintain canonical Wnt signaling, in part by directly repressing the Wnt antagonists Frzb and Shisa3 (shown by ChIP), and thereby promote mesenchymal proliferation.","method":"Conditional double mutant mice; genetic rescue; ChIP; expression profiling","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding of Tbx2/3 to target gene loci by ChIP, combined with genetic rescue experiments","pmids":["27720610"],"is_preprint":false},{"year":2011,"finding":"Genetic lineage tracing using Tbx2Cre shows that Tbx2+ primary myocardium of the AVC gives rise to the atrioventricular node; in Tbx2-deficient embryos, the AVC prematurely differentiates to chamber myocardium and proliferates at increased rates, demonstrating that Tbx2 temporally suppresses both differentiation and proliferation of primary myocardial cells.","method":"Genetic lineage tracing (Tbx2Cre knock-in); Tbx2-deficient embryo analysis; proliferation and marker analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — direct lineage tracing with functional loss-of-function validation","pmids":["19423846"],"is_preprint":false},{"year":2011,"finding":"Myocardium-specific inactivation of Tbx2 leads to formation of fast-conducting accessory pathways (Wolff-Parkinson-White-like), malformation of the annulus fibrosus, and ventricular preexcitation; the accessory pathways ectopically express fast-conduction proteins Cx40, Cx43, and Scn5a, establishing that Tbx2 is required for proper atrioventricular myocardial patterning to prevent accessory pathway formation.","method":"Conditional myocardium-specific Tbx2 knockout; electrophysiological recordings; immunohistochemistry for gap junction proteins","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — conditional knockout with defined molecular and electrophysiological phenotype","pmids":["21266775"],"is_preprint":false},{"year":2004,"finding":"Tbx2 represses Connexin43 (Cx43) promoter activity by directly binding two TCACAC T-box consensus sites in the Cx43 promoter; antisense-mediated downregulation of Tbx2 in osteosarcoma cells de-represses endogenous Cx43 expression and increases functional gap junction communication.","method":"In vitro binding assays; cotransfection reporter assays; promoter mutagenesis; antisense stable transfection; transgenic mouse analysis","journal":"Calcified tissue international","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding, mutagenesis, functional reporter assays, and endogenous gene expression validated in stable cell lines","pmids":["15354864"],"is_preprint":false},{"year":2012,"finding":"TBX2 directly represses E-cadherin transcription (shown by ChIP and reporter assays) and induces epithelial-mesenchymal transition (EMT); ectopic TBX2 in normal mammary epithelial cells causes loss of epithelial markers and gain of mesenchymal markers, increased invasion, and lung metastasis in xenografts.","method":"Ectopic TBX2 expression; TBX2 knockdown; ChIP; reporter assays; xenograft mouse model; EMT marker analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrates direct E-cadherin promoter binding; in vivo xenograft validates functional consequence","pmids":["22844464"],"is_preprint":false},{"year":2019,"finding":"TBX2 interacts with Heterochromatin Protein 1 (HP1) through a conserved HP1-binding motif in its N-terminus; this recruits KAP1, DNMT3B, and histone methyltransferase complex components (G9A, EZH2, SUZ12) to EGR1-targeted promoters (e.g., NDRG1), establishing H3K9me3 repressive marks. Mutation of the TBX2 HP1-binding domain abrogates this interaction and relieves target gene repression.","method":"Co-immunoprecipitation; HP1-binding motif mutagenesis; ChIP for H3K9me3 and complex components; siRNA knockdown; reporter assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical and chromatin assays with mutagenesis validation in a single study","pmids":["31253870"],"is_preprint":false},{"year":2014,"finding":"TBX2 directly represses the PTEN tumor suppressor promoter by binding it and recruiting HDAC1 in rhabdomyosarcoma and skeletal muscle cells; TBX2 depletion upregulates PTEN and reduces phospho-AKT, placing TBX2 in the PTEN/PI3K/AKT pathway.","method":"ChIP; HDAC1 recruitment assay; TBX2 knockdown/dominant-negative; Western blotting for phospho-AKT; xenograft tumor assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — direct ChIP evidence for promoter binding and co-repressor recruitment, functional validation in vivo","pmids":["26686089"],"is_preprint":false},{"year":2014,"finding":"TBX2 interacts with myogenic regulatory factors MyoD and myogenin and inhibits their transcriptional activity; TBX2 recruits HDAC1 to muscle-specific gene promoters to repress expression, blocking differentiation in rhabdomyosarcoma cells.","method":"Co-immunoprecipitation of TBX2 with MyoD/myogenin; ChIP for HDAC1; gene expression analysis; TBX2 depletion/dominant-negative; xenograft assay","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 — reciprocal protein interaction, ChIP, and functional validation with in vivo xenograft","pmids":["24470334"],"is_preprint":false},{"year":2011,"finding":"PML tumor suppressor directly represses TBX2 transcription through a p130/E2F4 repressor complex at the TBX2 promoter in senescence; conversely, elevated TBX2 antagonizes PML pro-senescence function through direct protein-protein interaction with PML, establishing an autoregulatory loop.","method":"Gene expression profiling; ChIP; promoter reporter assays; PML-TBX2 co-immunoprecipitation; TBX2 knockdown/depletion","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — direct promoter binding by ChIP, protein-protein interaction by co-IP, functional epistasis","pmids":["22002537"],"is_preprint":false},{"year":2012,"finding":"Retinoic acid (RA) directly downregulates Tbx2 expression through a functional retinoic acid response element (RARE) in the Tbx2 promoter; Tbx2 in turn activates Tgfb2 expression in the outflow tract, and the Tbx2-Tgfβ2 cascade is required for epithelial-mesenchymal transition in outflow tract cushion development.","method":"Identification of RARE in Tbx2 promoter; RA treatment of mouse embryos; Tgfb2 rescue in organ culture; gene expression analysis","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — RARE identified and functionally validated, Tgfb2 induction by Tbx2 in culture, rescue experiment","pmids":["22186728"],"is_preprint":false},{"year":2014,"finding":"TGF-β1 signaling upregulates TBX3, which then transcriptionally represses TBX2 expression, and this TBX2 downregulation mediates part of the anti-proliferative function of the TGF-β1-TBX3 axis.","method":"TGF-β1 treatment; TBX3 knockdown/overexpression; TBX2 promoter reporter assays; proliferation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway established by knockdown and reporter assays, single lab","pmids":["25371204"],"is_preprint":false},{"year":2013,"finding":"TBX2 co-represses CST6 (Cystatin 6) together with EGR1; this relieves Legumain (LGMN) from inhibition, sustaining breast cancer proliferation. CST6 expression in TBX2-expressing breast cancer cells induces apoptosis specifically through its LGMN-inhibitory domain.","method":"TBX2 knockdown; ectopic CST6 expression; CST6 domain mutagenesis; siRNA knockdown of LGMN; LGMN activity assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway validated by domain mutagenesis and enzymatic assays","pmids":["24742492"],"is_preprint":false},{"year":2017,"finding":"TBX2 acts in trans to promote transcription of the canonical WNT3A promoter in prostate cancer cells; blocking endogenous TBX2 reduces WNT3A expression, invasion, and bone metastasis, and genetic rescue of WNT3A partially restores TBX2-induced metastatic capability.","method":"Dominant-negative TBX2 construct; WNT3A promoter reporter assays; xenograft and intratibial mouse models; WNT3A rescue experiment; WNT3A-neutralizing antibodies","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — promoter activation assay combined with in vivo genetic rescue, single study","pmids":["28108510"],"is_preprint":false},{"year":2022,"finding":"Tbx2 is a master regulator of inner vs. outer hair cell (IHC vs. OHC) fate in the cochlea: ablation of Tbx2 in embryonic IHCs causes complete transdifferentiation into OHCs; ectopic Tbx2 in OHCs causes their transdifferentiation into IHCs. Tbx2 is epistatic to Insm1: in the absence of both, only OHCs form, indicating TBX2 is necessary for INSM1-deficient OHC-to-IHC transdifferentiation.","method":"Conditional knockout (hair cell-specific Cre); ectopic overexpression in OHCs; epistasis double knockout; marker analysis for IHC/OHC identity","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — reciprocal loss- and gain-of-function with genetic epistasis, multiple orthogonal approaches","pmids":["35508658"],"is_preprint":false},{"year":2022,"finding":"TBX2 specifies the inner compartment (IHCs and inner supporting cells) of the cochlear sensory epithelium; conditional deletion converts IHCs to OHCs (repressing IHC genes, inducing OHC genes including Ikzf2), and misexpression converts OHCs to IHCs. Coupled with transient Atoh1, Tbx2 can reprogram non-sensory supporting cells into IHC-like cells.","method":"Conditional deletion (hair cell- and progenitor-specific Cre); conditional misexpression; transdifferentiation/reprogramming assays; IHC/OHC marker profiling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — complementary loss- and gain-of-function approaches with molecular characterization","pmids":["36494345"],"is_preprint":false},{"year":2021,"finding":"TBX2 acts downstream of otocyst Tbx2/Tbx3-mediated repression of FGF signaling to restrict neurogenesis to the anterior-ventral otocyst; conditional Tbx2 ablation from the otocyst causes cochlear hypoplasia and posterior-ventral expansion of the neurogenic domain.","method":"Conditional knockout (otocyst-specific); expression analyses; FGF signaling readouts","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined molecular phenotype, single study","pmids":["33795231"],"is_preprint":false},{"year":2018,"finding":"TBX2 p.R20Q and p.R305H variants identified in patients with a DiGeorge-like syndrome show reduced transcriptional repressor activity and reduced protein levels in vitro; heterologous overexpression in Drosophila demonstrates both variants are partial loss-of-function alleles.","method":"In vitro transcriptional repression assays; protein level analysis; Drosophila overexpression assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays in two systems (human cells and Drosophila), single study","pmids":["29726930"],"is_preprint":false},{"year":2013,"finding":"Tbx2 and Msx1 can physically interact in mouse C3H10T1/2 cells; Tbx2 represses Bmp4 expression in dental mesenchyme, and reducing Tbx2 dosage (Msx1-/-;Tbx2+/- compound mutants) partially rescues the Msx1-/- bud-stage arrest and restores mesenchymal Bmp4 expression.","method":"Co-immunoprecipitation of Tbx2 and Msx1; Tbx2 knockdown in C3H10T1/2 cells; Bmp4 expression analysis; genetic compound mutant rescue","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — physical interaction demonstrated by co-IP, genetic epistasis rescue, and molecular phenotype","pmids":["23720046"],"is_preprint":false},{"year":2018,"finding":"TBX2 and TBX3 act downstream of canonical WNT signaling in the ureteric mesenchyme; ChIP reveals TBX2/TBX3 directly repress Dkk2, Shisa2 (WNT antagonists), Bmper (BMP antagonist), and Cxcl12; loss of TBX2/TBX3 disrupts Foxf1 and BMP4 signaling, reducing smooth muscle cell differentiation.","method":"Conditional double knockout mice; ChIP; transcriptional profiling; smooth muscle differentiation analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1-2 — direct chromatin binding by ChIP combined with conditional knockout and pathway analysis","pmids":["30478225"],"is_preprint":false},{"year":2013,"finding":"TBX2 interacts with HPV16 minor capsid protein L2, confirmed by co-immunoprecipitation and immunofluorescence; TBX2 (and TBX3) repress transcription from the HPV long control region (LCR) in reporter assays, and this repression is enhanced by L2; TBX2 binding to the HPV LCR was confirmed by ChIP.","method":"Yeast two-hybrid screening; co-immunoprecipitation; immunofluorescence; promoter reporter assays; ChIP","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — interaction confirmed by co-IP and ChIP, functional reporter assay, single study","pmids":["23388722"],"is_preprint":false},{"year":2018,"finding":"TBX2 is a constituent of the core regulatory circuitry in neuroblastoma; TBX2 drives proliferation through activation of FOXM1 target genes that are normally repressed by the p21-DREAM complex; combined TBX2/MYCN knockdown enforces cell growth arrest, indicating TBX2 enhances MYCN-sustained FOXM1 target activation.","method":"Epigenomic super-enhancer analysis; TBX2/MYCN knockdown; cell proliferation assays; gene expression profiling","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — functional epistasis between TBX2 and MYCN with defined transcriptional mechanism, single study","pmids":["30451831"],"is_preprint":false},{"year":2021,"finding":"TBX2 binds the promoter of miR-200c-3p and represses its expression; repression of miR-200c-3p increases SOX2 and N-MYC levels; this TBX2/miR-200c-3p/SOX2/N-MYC axis promotes neuroendocrine prostate cancer transdifferentiation both intracellularly and via exosome-mediated intercellular signaling.","method":"Promoter binding assay; miR profiling; rescue with miR-200c-3p re-expression; exosome co-culture experiments","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding, pathway rescue with miR-200c-3p, and exosome mechanism, single study","pmids":["34638504"],"is_preprint":false}],"current_model":"TBX2 is a T-box transcription factor that functions primarily as a transcriptional repressor: it directly binds variant T-box elements in target gene promoters (including p14ARF, p21WAF1, PTEN, E-cadherin, Grem1, Cdkn1a/b, Cx40, Cx43, ANF/Nppa) through its T-box DNA-binding domain and recruits corepressors (HDAC1, HP1/KAP1/EZH2/G9A complex) to silence these loci, thereby suppressing cellular senescence, maintaining progenitor/non-chamber cell identity in the heart AVC, driving proliferation in multiple tissues, and inducing EMT in cancer; its activity is regulated by p38 MAPK phosphorylation (serine 336/623/675), cell-cycle-dependent protein accumulation, interaction with Rb1 (which enhances DNA binding), upstream transcriptional activation by Mitf and BMP2/Smad signaling, and repression by Tbx20 (via Smad sequestration), PML/p130/E2F4, and TGF-β1/TBX3 signaling."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing TBX2 as a transcriptional repressor: TBX2 was shown to directly bind melanocyte promoter elements (MSEu/MSEi) and repress target gene (TRP-1) transcription, demonstrating that a T-box family member could function as a repressor rather than an activator.","evidence":"EMSA, site-directed mutagenesis, and cotransfection reporter assays in melanocyte/melanoma cells","pmids":["9710594"],"confidence":"High","gaps":["No corepressor mechanism identified","Repression domain not yet mapped"]},{"year":2000,"claim":"Linking TBX2 repression to senescence bypass and cancer: TBX2 was identified as an immortalizing factor that represses the p19ARF/p14ARF locus, explaining how overexpression could bypass oncogene-induced senescence—a central question for its oncogenic role.","evidence":"Genetic senescence bypass screen in Bmi1-deficient MEFs; promoter repression assays; binding to a variant T-site in the ARF promoter confirmed by mutagenesis","pmids":["11062467","12000749"],"confidence":"High","gaps":["Chromatin mechanism of repression at the ARF locus not determined","In vivo tumor suppressor pathway bypass not yet shown"]},{"year":2000,"claim":"Defining upstream regulators: Mitf and BMP2 signaling were established as direct transcriptional activators of TBX2, placing it within defined developmental and lineage-specific signaling cascades in melanocytes and cardiogenesis.","evidence":"Mitf binding to E-box in TBX2 promoter by EMSA with mutagenesis; BMP2 bead implantation in chick embryos and analysis of bmp2-null mouse embryos","pmids":["10770922","11087629"],"confidence":"High","gaps":["Smad-binding element in Tbx2 enhancer not yet identified","Relative contribution of Mitf vs. BMP2 in melanocytes unclear"]},{"year":2002,"claim":"Defining TBX2's cardiac patterning role: TBX2 cooperates with Nkx2.5 to repress ANF in atrioventricular canal myocardium, and domain analysis revealed both N-terminal and C-terminal repression domains, establishing the structural basis for context-dependent repression.","evidence":"Transgenic and in vivo mutagenesis of TBE/NKE elements; GAL4-deletion analysis of repression domains","pmids":["12023302","11867218"],"confidence":"High","gaps":["Corepressor identity for cardiac targets unknown","Crystal structure of TBX2 repression domains not available"]},{"year":2004,"claim":"Identifying HDAC1 as a TBX2-recruited corepressor and expanding target gene repertoire: TBX2 directly binds p21WAF1 and Cx43 promoters and recruits HDAC1 to mediate repression, providing the first chromatin-modifying mechanism for TBX2-dependent silencing.","evidence":"ChIP for TBX2 and HDAC1 at the p21 promoter; siRNA knockdown; in vitro binding and mutagenesis of Cx43 T-box sites","pmids":["14996726","15781639","15354864"],"confidence":"High","gaps":["Whether HDAC1 recruitment is universal across all TBX2 targets not tested","Structural basis of TBX2-HDAC1 interaction unknown"]},{"year":2004,"claim":"In vivo requirement for TBX2 in cardiac chamber patterning: Tbx2-null and Tbx2-overexpressing mice demonstrated that TBX2 is both necessary and sufficient to suppress chamber myocardium gene expression in the AVC, establishing its role as a binary cell-fate switch in heart morphogenesis.","evidence":"Targeted Tbx2 knockout and transgenic overexpression in mice with marker gene analysis","pmids":["15042700","15459098"],"confidence":"High","gaps":["Redundancy with Tbx3 not yet quantified","Direct chromatin targets in AVC not genome-wide mapped"]},{"year":2007,"claim":"Post-translational regulation resolved: p38 MAPK phosphorylates TBX2 at S336/S623/S675 upon UV stress, stabilizing the protein and enhancing nuclear accumulation and p21 repressor activity—explaining how stress signals modulate TBX2 function.","evidence":"In vitro kinase assays; phospho-site mutagenesis; immunofluorescence; reporter assays","pmids":["18025091"],"confidence":"High","gaps":["Other kinases that target TBX2 not surveyed","Phosphorylation effects on non-p21 targets not examined"]},{"year":2009,"claim":"Tbx20 restricts Tbx2 expression by a non-canonical mechanism: Tbx20 sequesters Smad1/5 away from Smad4, attenuating BMP-dependent activation of the Tbx2 AVC enhancer—resolving how chamber myocardium excludes Tbx2.","evidence":"Single and double knockout embryos; identification of BMP/Smad-dependent Tbx2 enhancer; Smad co-immunoprecipitation","pmids":["19661464"],"confidence":"High","gaps":["Whether Tbx20 regulation of Tbx2 operates in non-cardiac tissues unknown","Direct Smad4-enhancer binding not shown by ChIP"]},{"year":2010,"claim":"Rb1 interaction enhances TBX2 function: TBX2 specifically binds hypophosphorylated Rb1 (not p107/p130) via a C-terminal domain, augmenting DNA binding and expanding target gene selectivity, linking TBX2 repression to the cell-cycle machinery.","evidence":"Co-immunoprecipitation; domain mapping; microarray with inducible dominant-negative TBX2 carrying Rb1-interaction domain mutation","pmids":["20534814"],"confidence":"High","gaps":["Structural basis of TBX2-Rb1 interaction not resolved","Whether Rb1 is required for TBX2 function at all targets not determined"]},{"year":2011,"claim":"Functional consequences of cardiac Tbx2 loss defined at the electrophysiological level: myocardium-specific Tbx2 deletion causes accessory pathway formation (Wolff-Parkinson-White-like phenotype) with ectopic Cx40/Cx43/Scn5a expression, establishing TBX2 as essential for annulus fibrosus integrity and prevention of ventricular preexcitation.","evidence":"Conditional myocardium-specific knockout; electrophysiological recordings; immunohistochemistry","pmids":["21266775"],"confidence":"High","gaps":["Whether human WPW cases involve TBX2 mutations not established","Relative contribution of Cx40 vs. Cx43 derepression to accessory pathway conduction not parsed"]},{"year":2011,"claim":"PML-TBX2 autoregulatory loop in senescence: PML represses TBX2 transcription via a p130/E2F4 complex, while TBX2 protein antagonizes PML's pro-senescence function through direct binding, establishing a feedback circuit governing cellular senescence.","evidence":"ChIP at TBX2 promoter; co-immunoprecipitation of PML-TBX2; knockdown experiments","pmids":["22002537"],"confidence":"High","gaps":["In vivo significance of PML-TBX2 loop in tumor suppression not tested","Whether TBX2 disrupts PML nuclear bodies not examined"]},{"year":2013,"claim":"TBX2 controls organ growth by direct repression of CDK inhibitors: ChIP demonstrated TBX2 occupancy at Cdkn1a/Cdkn1b loci in lung mesenchyme, and genetic deletion of both CDK inhibitors rescued lung hypoplasia of Tbx2-null mice, proving these are the critical proliferation targets.","evidence":"Conditional knockout; double Cdkn1a/Cdkn1b genetic rescue; ChIP in lung tissue","pmids":["23341776"],"confidence":"High","gaps":["Whether additional Tbx2 targets contribute to lung growth not excluded","Tbx2 targets in lung epithelium not addressed"]},{"year":2013,"claim":"TBX2 terminates the Shh/Fgf signaling loop in limb development: direct repression of Grem1 by TBX2 in posterior limb mesenchyme times the cessation of digit-forming signals, with loss causing polydactyly and gain causing premature loop termination.","evidence":"Conditional Tbx2 knockout and overexpression in mouse limbs; ChIP at Grem1 locus; digit phenotype analysis","pmids":["23633963"],"confidence":"High","gaps":["Whether TBX2 and TBX3 have distinct Grem1-regulatory roles not resolved","Mechanism by which TBX2 selectively targets posterior mesenchyme unclear"]},{"year":2019,"claim":"A second corepressor mechanism elucidated: TBX2 recruits the HP1/KAP1/G9A/EZH2 complex via an N-terminal HP1-binding motif to establish H3K9me3 at target promoters, revealing a heterochromatin-based silencing pathway distinct from HDAC1 recruitment.","evidence":"Co-immunoprecipitation; HP1-binding motif mutagenesis; ChIP for H3K9me3 and complex components; siRNA knockdown","pmids":["31253870"],"confidence":"High","gaps":["Which targets use HP1 versus HDAC1 pathway not globally defined","Whether both pathways operate simultaneously at the same locus unknown"]},{"year":2022,"claim":"TBX2 identified as the master binary switch for cochlear hair cell fate: ablation converts inner hair cells to outer hair cells and ectopic expression converts outer to inner, demonstrating sufficiency and necessity for inner hair cell identity—a previously unresolved question in auditory biology.","evidence":"Conditional knockout and ectopic expression in hair cells; epistasis with Insm1; IHC/OHC marker profiling","pmids":["35508658","36494345"],"confidence":"High","gaps":["Direct transcriptional targets that mediate IHC specification not genome-wide identified","Whether TBX2 maintains IHC identity in the adult cochlea not fully tested","Therapeutic potential for hearing restoration via TBX2 manipulation not validated"]},{"year":null,"claim":"Key unresolved questions include: (1) the genome-wide partitioning of HDAC1- versus HP1/EZH2-dependent repression across TBX2 target genes; (2) a structural model of TBX2 bound to DNA and corepressor complexes; (3) whether TBX2 functions as a transcriptional activator at select loci in vivo (as suggested for WNT3A and Tgfb2) or only indirectly; (4) the full repertoire of post-translational modifications beyond p38-mediated phosphorylation.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal/cryo-EM structure of TBX2","Genome-wide corepressor usage not mapped","Activator function not confirmed by ChIP for activating marks"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,5,6,20,21]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3,4,5,7,21,22,23]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,11]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,4,10,12,15]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,3,5,7,22,23]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,9,13,16,18,30,31,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,13,17,29,35]}],"complexes":[],"partners":["NKX2-5","HDAC1","RB1","PML","CBX5","MSX1","MYOD1"],"other_free_text":[]},"mechanistic_narrative":"TBX2 is a T-box transcription factor that functions as a transcriptional repressor to control cell proliferation, differentiation, and tissue patterning across multiple organ systems. It binds variant T-box elements as a monomer through its T-box DNA-binding domain and recruits corepressor complexes—including HDAC1 and an HP1/KAP1/EZH2/G9A chromatin-silencing module—to establish repressive histone marks (H3K9me3) at target promoters such as p14ARF, p21WAF1, PTEN, E-cadherin, Cx40/Cx43, and Grem1, thereby suppressing senescence, blocking differentiation, and promoting proliferation [PMID:11062467, PMID:14996726, PMID:31253870, PMID:26686089]. In the heart, TBX2 maintains atrioventricular canal identity by repressing chamber-specific genes, and its loss causes accessory pathway formation and ventricular preexcitation; in the cochlea, TBX2 is the master determinant of inner hair cell versus outer hair cell fate, with its deletion or ectopic expression sufficient to switch cell identity [PMID:15042700, PMID:21266775, PMID:35508658]. TBX2 activity is regulated by BMP2/Smad signaling, Mitf-dependent transcription, p38 MAPK phosphorylation, interaction with hypophosphorylated Rb1, and antagonism by Tbx20-mediated Smad sequestration and PML/p130/E2F4-dependent transcriptional repression of the TBX2 locus [PMID:11087629, PMID:18025091, PMID:20534814, PMID:19661464, PMID:22002537]. Partial loss-of-function TBX2 variants (R20Q, R305H) have been identified in patients with a DiGeorge-like syndrome [PMID:29726930]."},"prefetch_data":{"uniprot":{"accession":"Q13207","full_name":"T-box transcription factor TBX2","aliases":[],"length_aa":712,"mass_kda":75.1,"function":"Transcription factor which acts as a transcriptional repressor (PubMed:11062467, PubMed:11111039, PubMed:12000749, PubMed:22844464, PubMed:30599067). May also function as a transcriptional activator (By similarity). Binds to the palindromic T site 5'-TTCACACCTAGGTGTGAA-3' DNA sequence, or a half-site, which are present in the regulatory region of several genes (PubMed:11111039, PubMed:12000749, PubMed:22844464, PubMed:30599067). Required for cardiac atrioventricular canal formation (PubMed:29726930). May cooperate with NKX2.5 to negatively modulate expression of NPPA/ANF in the atrioventricular canal (By similarity). May play a role as a positive regulator of TGFB2 expression, perhaps acting in concert with GATA4 in the developing outflow tract myocardium (By similarity). Plays a role in limb pattern formation (PubMed:29726930). Acts as a transcriptional repressor of ADAM10 gene expression, perhaps in concert with histone deacetylase HDAC1 as cofactor (PubMed:30599067). Involved in branching morphogenesis in both developing lungs and adult mammary glands, via negative modulation of target genes; acting redundantly with TBX3 (By similarity). Required, together with TBX3, to maintain cell proliferation in the embryonic lung mesenchyme; perhaps acting downstream of SHH, BMP and TGFbeta signaling (By similarity). Involved in modulating early inner ear development, acting independently of, and also redundantly with TBX3, in different subregions of the developing ear (By similarity). Acts as a negative regulator of PML function in cellular senescence (PubMed:22002537). Acts as a negative regulator of expression of CDKN1A/p21, IL33 and CCN4; repression of CDKN1A is enhanced in response to UV-induced stress, perhaps as a result of phosphorylation by p38 MAPK (By similarity). Negatively modulates expression of CDKN2A/p14ARF and CDH1/E-cadherin (PubMed:11062467, PubMed:12000749, PubMed:22844464). Plays a role in induction of the epithelial-mesenchymal transition (EMT) (PubMed:22844464). Plays a role in melanocyte proliferation, perhaps via regulation of cyclin CCND1 (By similarity). Involved in melanogenesis, acting via negative modulation of expression of DHICA oxidase/TYRP1 and P protein/OCA2 (By similarity). Involved in regulating retinal pigment epithelium (RPE) cell proliferation, perhaps via negatively modulating transcription of the transcription factor CEBPD (PubMed:28910203)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13207/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TBX2","classification":"Not Classified","n_dependent_lines":39,"n_total_lines":1208,"dependency_fraction":0.03228476821192053},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TBX2","total_profiled":1310},"omim":[{"mim_id":"621295","title":"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY 1; CARASIL1","url":"https://www.omim.org/entry/621295"},{"mim_id":"618223","title":"VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD","url":"https://www.omim.org/entry/618223"},{"mim_id":"613665","title":"ATYPICAL CHEMOKINE RECEPTOR 1; ACKR1","url":"https://www.omim.org/entry/613665"},{"mim_id":"613355","title":"CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME","url":"https://www.omim.org/entry/613355"},{"mim_id":"606061","title":"T-BOX TRANSCRIPTION FACTOR 20; TBX20","url":"https://www.omim.org/entry/606061"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lung","ntpm":71.7}],"url":"https://www.proteinatlas.org/search/TBX2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q13207","domains":[{"cath_id":"2.60.40.820","chopping":"107-280","consensus_level":"high","plddt":95.9626,"start":107,"end":280}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13207","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13207-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13207-F1-predicted_aligned_error_v6.png","plddt_mean":56.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBX2","jax_strain_url":"https://www.jax.org/strain/search?query=TBX2"},"sequence":{"accession":"Q13207","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13207.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13207/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13207"}},"corpus_meta":[{"pmid":"11062467","id":"PMC_11062467","title":"Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11062467","citation_count":318,"is_preprint":false},{"pmid":"12023302","id":"PMC_12023302","title":"Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12023302","citation_count":292,"is_preprint":false},{"pmid":"15459098","id":"PMC_15459098","title":"Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15459098","citation_count":230,"is_preprint":false},{"pmid":"15042700","id":"PMC_15042700","title":"T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15042700","citation_count":205,"is_preprint":false},{"pmid":"15781639","id":"PMC_15781639","title":"Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15781639","citation_count":183,"is_preprint":false},{"pmid":"11087629","id":"PMC_11087629","title":"Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11087629","citation_count":170,"is_preprint":false},{"pmid":"15901664","id":"PMC_15901664","title":"Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15901664","citation_count":160,"is_preprint":false},{"pmid":"9710594","id":"PMC_9710594","title":"Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710594","citation_count":149,"is_preprint":false},{"pmid":"9609833","id":"PMC_9609833","title":"Involvement of T-box genes Tbx2-Tbx5 in vertebrate limb specification and development.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9609833","citation_count":144,"is_preprint":false},{"pmid":"9651516","id":"PMC_9651516","title":"Expression of T-box genes Tbx2-Tbx5 during chick organogenesis.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9651516","citation_count":140,"is_preprint":false},{"pmid":"12000749","id":"PMC_12000749","title":"The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12000749","citation_count":135,"is_preprint":false},{"pmid":"14996726","id":"PMC_14996726","title":"Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14996726","citation_count":133,"is_preprint":false},{"pmid":"19423846","id":"PMC_19423846","title":"The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19423846","citation_count":131,"is_preprint":false},{"pmid":"22130515","id":"PMC_22130515","title":"Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation.","date":"2011","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22130515","citation_count":114,"is_preprint":false},{"pmid":"17141161","id":"PMC_17141161","title":"Regional morphogenesis in the hypothalamus: a BMP-Tbx2 pathway coordinates fate and proliferation through Shh downregulation.","date":"2006","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/17141161","citation_count":111,"is_preprint":false},{"pmid":"19960541","id":"PMC_19960541","title":"The T-box transcription factor Tbx2: its role in development and possible implication in cancer.","date":"2010","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/19960541","citation_count":105,"is_preprint":false},{"pmid":"17259303","id":"PMC_17259303","title":"Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17259303","citation_count":103,"is_preprint":false},{"pmid":"12086464","id":"PMC_12086464","title":"FGF signaling regulates expression of Tbx2, Erm, Pea3, and Pax3 in the early nasal region.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12086464","citation_count":102,"is_preprint":false},{"pmid":"19661464","id":"PMC_19661464","title":"Tbx20 interacts with smads to confine tbx2 expression to the atrioventricular canal.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19661464","citation_count":95,"is_preprint":false},{"pmid":"10770922","id":"PMC_10770922","title":"The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10770922","citation_count":88,"is_preprint":false},{"pmid":"17460765","id":"PMC_17460765","title":"Tbx2 and Tbx3 regulate the dynamics of cell proliferation during heart remodeling.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17460765","citation_count":84,"is_preprint":false},{"pmid":"30451831","id":"PMC_30451831","title":"TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30451831","citation_count":84,"is_preprint":false},{"pmid":"15300007","id":"PMC_15300007","title":"The role of Tbx2 and Tbx3 in mammary development and tumorigenesis.","date":"2004","source":"Journal of mammary gland biology and neoplasia","url":"https://pubmed.ncbi.nlm.nih.gov/15300007","citation_count":80,"is_preprint":false},{"pmid":"21779450","id":"PMC_21779450","title":"The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process.","date":"2010","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21779450","citation_count":76,"is_preprint":false},{"pmid":"11111039","id":"PMC_11111039","title":"Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11111039","citation_count":75,"is_preprint":false},{"pmid":"21266775","id":"PMC_21266775","title":"Defective Tbx2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21266775","citation_count":73,"is_preprint":false},{"pmid":"16222716","id":"PMC_16222716","title":"Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16222716","citation_count":70,"is_preprint":false},{"pmid":"12097257","id":"PMC_12097257","title":"TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12097257","citation_count":69,"is_preprint":false},{"pmid":"10704879","id":"PMC_10704879","title":"Conserved and divergent expression of T-box genes Tbx2-Tbx5 in Xenopus.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10704879","citation_count":68,"is_preprint":false},{"pmid":"35508658","id":"PMC_35508658","title":"Tbx2 is a master regulator of inner versus outer hair cell differentiation.","date":"2022","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/35508658","citation_count":64,"is_preprint":false},{"pmid":"23341776","id":"PMC_23341776","title":"Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23341776","citation_count":64,"is_preprint":false},{"pmid":"22116936","id":"PMC_22116936","title":"Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22116936","citation_count":61,"is_preprint":false},{"pmid":"21567896","id":"PMC_21567896","title":"Wnt signaling regulates atrioventricular canal formation upstream of BMP and Tbx2.","date":"2011","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/21567896","citation_count":61,"is_preprint":false},{"pmid":"8530034","id":"PMC_8530034","title":"Cloning and mapping of a human gene (TBX2) sharing a highly conserved protein motif with the Drosophila omb gene.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530034","citation_count":60,"is_preprint":false},{"pmid":"23624936","id":"PMC_23624936","title":"The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer.","date":"2013","source":"Journal of mammary gland biology and neoplasia","url":"https://pubmed.ncbi.nlm.nih.gov/23624936","citation_count":59,"is_preprint":false},{"pmid":"28108510","id":"PMC_28108510","title":"Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28108510","citation_count":59,"is_preprint":false},{"pmid":"29726930","id":"PMC_29726930","title":"Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29726930","citation_count":59,"is_preprint":false},{"pmid":"11867218","id":"PMC_11867218","title":"Murine Tbx2 contains domains that activate and repress gene transcription.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11867218","citation_count":57,"is_preprint":false},{"pmid":"27720610","id":"PMC_27720610","title":"Tbx2 and Tbx3 Act Downstream of Shh to Maintain Canonical Wnt Signaling during Branching Morphogenesis of the Murine Lung.","date":"2016","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/27720610","citation_count":57,"is_preprint":false},{"pmid":"21271665","id":"PMC_21271665","title":"Microdeletion of 17q22q23.2 encompassing TBX2 and TBX4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21271665","citation_count":54,"is_preprint":false},{"pmid":"20624445","id":"PMC_20624445","title":"TBX2 and TBX3: the special value for anticancer drug targets.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20624445","citation_count":54,"is_preprint":false},{"pmid":"16701625","id":"PMC_16701625","title":"The T-box factor TBX-2 and the SUMO conjugating enzyme UBC-9 are required for ABa-derived pharyngeal muscle in C. elegans.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16701625","citation_count":54,"is_preprint":false},{"pmid":"22844464","id":"PMC_22844464","title":"The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22844464","citation_count":51,"is_preprint":false},{"pmid":"18815807","id":"PMC_18815807","title":"Conservation of linkage and evolution of developmental function within the Tbx2/3/4/5 subfamily of T-box genes: implications for the origin of vertebrate limbs.","date":"2008","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/18815807","citation_count":48,"is_preprint":false},{"pmid":"23633963","id":"PMC_23633963","title":"Tbx2 terminates shh/fgf signaling in the developing mouse limb bud by direct repression of gremlin1.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23633963","citation_count":48,"is_preprint":false},{"pmid":"17300775","id":"PMC_17300775","title":"Characterization of a novel ectodermal signaling center regulating Tbx2 and Shh in the vertebrate limb.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17300775","citation_count":45,"is_preprint":false},{"pmid":"20229117","id":"PMC_20229117","title":"Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens.","date":"2010","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20229117","citation_count":45,"is_preprint":false},{"pmid":"17700536","id":"PMC_17700536","title":"Ectopic Tbx2 expression results in polyploidy and cisplatin resistance.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17700536","citation_count":44,"is_preprint":false},{"pmid":"12782273","id":"PMC_12782273","title":"Coquillette, a sea urchin T-box gene of the Tbx2 subfamily, is expressed asymmetrically along the oral-aboral axis of the embryo and is involved in skeletogenesis.","date":"2003","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12782273","citation_count":42,"is_preprint":false},{"pmid":"15236312","id":"PMC_15236312","title":"ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.","date":"2004","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15236312","citation_count":42,"is_preprint":false},{"pmid":"25394776","id":"PMC_25394776","title":"Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.","date":"2014","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/25394776","citation_count":41,"is_preprint":false},{"pmid":"31253870","id":"PMC_31253870","title":"TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31253870","citation_count":40,"is_preprint":false},{"pmid":"22186728","id":"PMC_22186728","title":"Ectopic retinoic acid signaling affects outflow tract cushion development through suppression of the myocardial Tbx2-Tgfβ2 pathway.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22186728","citation_count":40,"is_preprint":false},{"pmid":"25371204","id":"PMC_25371204","title":"The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25371204","citation_count":39,"is_preprint":false},{"pmid":"16730707","id":"PMC_16730707","title":"Cell cycle regulation of the T-box transcription factor tbx2.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16730707","citation_count":39,"is_preprint":false},{"pmid":"8597636","id":"PMC_8597636","title":"Identification, characterization, and localization to chromosome 17q21-22 of the human TBX2 homolog, member of a conserved developmental gene family.","date":"1995","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/8597636","citation_count":39,"is_preprint":false},{"pmid":"33795231","id":"PMC_33795231","title":"Regulation of otocyst patterning by Tbx2 and Tbx3 is required for inner ear morphogenesis in the mouse.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33795231","citation_count":38,"is_preprint":false},{"pmid":"13680223","id":"PMC_13680223","title":"Distinct expression patterns of the two T-box homologues Brachyury and Tbx2/3 in the placozoan Trichoplax adhaerens.","date":"2003","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/13680223","citation_count":38,"is_preprint":false},{"pmid":"24742492","id":"PMC_24742492","title":"TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24742492","citation_count":38,"is_preprint":false},{"pmid":"20502058","id":"PMC_20502058","title":"Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma.","date":"2010","source":"Onkologie","url":"https://pubmed.ncbi.nlm.nih.gov/20502058","citation_count":37,"is_preprint":false},{"pmid":"18025091","id":"PMC_18025091","title":"UV-mediated regulation of the anti-senescence factor Tbx2.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18025091","citation_count":37,"is_preprint":false},{"pmid":"17005176","id":"PMC_17005176","title":"Role of T-box gene tbx-2 for anterior foregut muscle development in C. elegans.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17005176","citation_count":36,"is_preprint":false},{"pmid":"19769959","id":"PMC_19769959","title":"Expression and requirement of T-box transcription factors Tbx2 and Tbx3 during secondary palate development in the mouse.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19769959","citation_count":35,"is_preprint":false},{"pmid":"14750151","id":"PMC_14750151","title":"TBX2/TBX3 transcriptional factor homologue controls olfactory adaptation in Caenorhabditis elegans.","date":"2004","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/14750151","citation_count":35,"is_preprint":false},{"pmid":"19563797","id":"PMC_19563797","title":"Tbx2 misexpression impairs deployment of second heart field derived progenitor cells to the arterial pole of the embryonic heart.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19563797","citation_count":35,"is_preprint":false},{"pmid":"22002537","id":"PMC_22002537","title":"Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22002537","citation_count":33,"is_preprint":false},{"pmid":"12175361","id":"PMC_12175361","title":"Conserved expression control and shared activity between cognate T-box genes Tbx2 and Tbx3 in connection with Sonic hedgehog signaling during Xenopus eye development.","date":"2002","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/12175361","citation_count":33,"is_preprint":false},{"pmid":"26686089","id":"PMC_26686089","title":"TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26686089","citation_count":32,"is_preprint":false},{"pmid":"19576202","id":"PMC_19576202","title":"Loss of Tbx2 delays optic vesicle invagination leading to small optic cups.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19576202","citation_count":32,"is_preprint":false},{"pmid":"23674602","id":"PMC_23674602","title":"Tbx2/3 is an essential mediator within the Brachyury gene network during Ciona notochord development.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23674602","citation_count":32,"is_preprint":false},{"pmid":"36494345","id":"PMC_36494345","title":"TBX2 specifies and maintains inner hair and supporting cell fate in the Organ of Corti.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36494345","citation_count":32,"is_preprint":false},{"pmid":"36687561","id":"PMC_36687561","title":"Development and transdifferentiation into inner hair cells require Tbx2.","date":"2022","source":"National science review","url":"https://pubmed.ncbi.nlm.nih.gov/36687561","citation_count":31,"is_preprint":false},{"pmid":"18534921","id":"PMC_18534921","title":"Expression of Tbx2 and Tbx3 in the developing hypothalamic-pituitary axis.","date":"2008","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/18534921","citation_count":31,"is_preprint":false},{"pmid":"24470334","id":"PMC_24470334","title":"TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24470334","citation_count":30,"is_preprint":false},{"pmid":"23720046","id":"PMC_23720046","title":"Msx1 and Tbx2 antagonistically regulate Bmp4 expression during the bud-to-cap stage transition in tooth development.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23720046","citation_count":29,"is_preprint":false},{"pmid":"20534814","id":"PMC_20534814","title":"The retinoblastoma protein modulates Tbx2 functional specificity.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20534814","citation_count":29,"is_preprint":false},{"pmid":"15354864","id":"PMC_15354864","title":"Tbx2 represses expression of Connexin43 in osteoblastic-like cells.","date":"2004","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/15354864","citation_count":29,"is_preprint":false},{"pmid":"30478225","id":"PMC_30478225","title":"TBX2 and TBX3 act downstream of canonical WNT signaling in patterning and differentiation of the mouse ureteric mesenchyme.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30478225","citation_count":28,"is_preprint":false},{"pmid":"29719592","id":"PMC_29719592","title":"EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29719592","citation_count":28,"is_preprint":false},{"pmid":"16477648","id":"PMC_16477648","title":"Developmental expression patterns of Tbx1, Tbx2, Tbx5, and Tbx20 in Xenopus tropicalis.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16477648","citation_count":28,"is_preprint":false},{"pmid":"24113180","id":"PMC_24113180","title":"A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24113180","citation_count":27,"is_preprint":false},{"pmid":"21205791","id":"PMC_21205791","title":"Role of Tbx2 in defining the territory of the pronephric nephron.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21205791","citation_count":23,"is_preprint":false},{"pmid":"19216023","id":"PMC_19216023","title":"Expression of TBX2 promotes anchorage-independent growth and survival in the p53-negative SW13 adrenocortical carcinoma.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/19216023","citation_count":22,"is_preprint":false},{"pmid":"23388722","id":"PMC_23388722","title":"The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.","date":"2013","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/23388722","citation_count":22,"is_preprint":false},{"pmid":"23585355","id":"PMC_23585355","title":"Brachyury, Tbx2/3 and sall expression during embryogenesis of the indirectly developing polychaete Hydroides elegans.","date":"2013","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23585355","citation_count":21,"is_preprint":false},{"pmid":"10552304","id":"PMC_10552304","title":"Expression of Xenopus T-box transcription factor, tbx2 in Xenopus embryo.","date":"1999","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/10552304","citation_count":21,"is_preprint":false},{"pmid":"30866410","id":"PMC_30866410","title":"Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30866410","citation_count":21,"is_preprint":false},{"pmid":"22223620","id":"PMC_22223620","title":"Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/22223620","citation_count":20,"is_preprint":false},{"pmid":"23020925","id":"PMC_23020925","title":"TBX2 expression is regulated by PAX3 in the melanocyte lineage.","date":"2012","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/23020925","citation_count":20,"is_preprint":false},{"pmid":"20635360","id":"PMC_20635360","title":"TBX2 gene duplication associated with complex heart defect and skeletal malformations.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20635360","citation_count":19,"is_preprint":false},{"pmid":"21448936","id":"PMC_21448936","title":"Heart chamber size in zebrafish is regulated redundantly by duplicated tbx2 genes.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21448936","citation_count":19,"is_preprint":false},{"pmid":"27913219","id":"PMC_27913219","title":"Tbx2 regulates anterior neural specification by repressing FGF signaling pathway.","date":"2016","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27913219","citation_count":18,"is_preprint":false},{"pmid":"30223900","id":"PMC_30223900","title":"Identification of TBX2 and TBX3 variants in patients with conotruncal heart defects by target sequencing.","date":"2018","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30223900","citation_count":18,"is_preprint":false},{"pmid":"30651856","id":"PMC_30651856","title":"TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.","date":"2018","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30651856","citation_count":18,"is_preprint":false},{"pmid":"34638504","id":"PMC_34638504","title":"TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34638504","citation_count":18,"is_preprint":false},{"pmid":"25344916","id":"PMC_25344916","title":"The orthologous Tbx transcription factors Omb and TBX2 induce epithelial cell migration and extrusion in vivo without involvement of matrix metalloproteinases.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25344916","citation_count":18,"is_preprint":false},{"pmid":"16122738","id":"PMC_16122738","title":"T-box and homeobox genes from the ctenophore Pleurobrachia pileus: comparison of Brachyury, Tbx2/3 and Tlx in basal metazoans and bilaterians.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/16122738","citation_count":18,"is_preprint":false},{"pmid":"15850455","id":"PMC_15850455","title":"Expression pattern of the Brachyury and Tbx2 homologues from the sponge Suberites domuncula.","date":"2005","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15850455","citation_count":17,"is_preprint":false},{"pmid":"28881763","id":"PMC_28881763","title":"TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28881763","citation_count":17,"is_preprint":false},{"pmid":"20095052","id":"PMC_20095052","title":"Generation of mice with a conditional null allele for Tbx2.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/20095052","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48132,"output_tokens":9021,"usd":0.139855},"stage2":{"model":"claude-opus-4-6","input_tokens":12868,"output_tokens":4178,"usd":0.253185},"total_usd":0.39304,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"TBX2 represses the Cdkn2a (p19ARF) promoter and attenuates E2F1, Myc, and HRAS-mediated induction of p19ARF, thereby bypassing cellular senescence and enabling immortalization.\",\n      \"method\": \"Genetic senescence bypass screen in Bmi1-deficient fibroblasts; promoter repression assays; transfection studies\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays, widely replicated across many subsequent studies\",\n      \"pmids\": [\"11062467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TBX2 forms a complex with Nkx2.5 on the ANF promoter T-box binding element (TBE)-NK2 homeobox element (NKE) to cooperatively repress ANF gene expression in the atrioventricular canal myocardium.\",\n      \"method\": \"Transgenic analysis; in vivo mutagenesis of TBE and NKE elements; cotransfection/reporter assays; protein-protein interaction studies\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vivo transgenic validation and binding element mutagenesis\",\n      \"pmids\": [\"12023302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tbx2 is required to repress chamber myocardium-specific genes (Nppa, Cx40, Cx43, Chisel) in the atrioventricular canal; transgenic overexpression of Tbx2 in prechamber myocardium completely blocks chamber formation and suppresses chamber-specific gene expression.\",\n      \"method\": \"Targeted mutagenesis (Tbx2 null mice); transgenic overexpression; molecular analysis of marker gene expression\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function mouse models with defined molecular phenotype, corroborated by independent study (PMID:15459098)\",\n      \"pmids\": [\"15042700\", \"15459098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TBX2 and TBX3 specifically bind a variant T-site (13/20 nucleotide match to consensus) in the human p14ARF promoter to repress its transcription; both the core T-box DNA-binding domain and a C-terminal conserved repression domain are required for p14ARF repression.\",\n      \"method\": \"Mutant analysis of promoter T-site; deletion/domain mutagenesis; transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding and mutagenesis with functional reporter validation\",\n      \"pmids\": [\"12000749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tbx2 directly binds and represses the p21(WAF1) promoter in vitro and in vivo; siRNA-mediated knockdown of Tbx2 robustly activates p21 expression. Tbx2 targets histone deacetylase 1 (HDAC1) to the p21 initiator to mediate repression.\",\n      \"method\": \"In vitro DNA-binding assays; transfection reporter assays; chromatin immunoprecipitation (ChIP); siRNA knockdown; inducible dominant-negative Tbx2\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro binding with functional validation\",\n      \"pmids\": [\"14996726\", \"15781639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TBX2 acts as a transcriptional repressor by binding the MSEu and MSEi elements of the TRP-1 promoter; mutations in these elements that abolish TBX2 binding derepress TRP-1 promoter activity in melanocytes and melanoma cells. A high-affinity consensus Tbx2-binding site can constitutively repress a heterologous promoter.\",\n      \"method\": \"Electrophoretic mobility shift assays; cotransfection reporter assays; site-directed mutagenesis of promoter elements\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding combined with mutagenesis and functional reporter assays\",\n      \"pmids\": [\"9710594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TBX2 binds a palindromic T-oligonucleotide as a monomer (unlike Xbra which binds as a dimer) and represses transcription from a chimeric reporter, whereas Xbra activates the same promoter, demonstrating distinct DNA-binding stoichiometry and transcriptional modulation properties.\",\n      \"method\": \"In vitro DNA binding assays; cotransfection reporter assays; antibody supershift assays\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization with functional reporter validation\",\n      \"pmids\": [\"11111039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Murine Tbx2 contains two transcriptional repression domains: a C-terminal domain conserved with Tbx3/ET, and a novel N-terminal domain (amino-terminal to the T-box); the T-box itself can weakly activate transcription in a promoter-context-dependent manner.\",\n      \"method\": \"Deletion analysis linked to GAL4 DNA-binding domain; cotransfection reporter assays\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion analysis with functional readout, single lab\",\n      \"pmids\": [\"11867218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The Tbx2 promoter contains a full consensus Mitf (microphthalmia-associated transcription factor) recognition E-box element; Mitf binds the Tbx2 promoter in vitro and activates Tbx2 expression in vivo in an E-box-dependent manner, placing Tbx2 as a direct transcriptional target of Mitf in the melanocyte lineage.\",\n      \"method\": \"Promoter sequencing; in vitro binding (EMSA); in vivo transfection; E-box mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding confirmed with in vivo activation and mutagenesis\",\n      \"pmids\": [\"10770922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BMP2 signaling induces Tbx2 (and Tbx3) expression in non-cardiogenic embryonic tissue; the BMP antagonist Noggin downregulates Tbx2 gene activity; Tbx2 expression is absent in bmp2 null mouse embryos, placing Tbx2 downstream of BMP2 signaling in early cardiogenesis.\",\n      \"method\": \"BMP2 bead application to chick embryos; Noggin treatment; analysis of bmp2 null mouse embryos\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function (bead application), loss-of-function (Noggin, knockout mouse), replicated in multiple systems\",\n      \"pmids\": [\"11087629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tbx2 protein levels are cell-cycle regulated: low in G1, rising through S-phase, persisting through G2, then dramatically reduced at mitosis onset. In S-phase, Tbx2 localizes to a subset of late replication foci and to small subnuclear DNA-associated foci distinct from telomeres, PML or Cajal bodies.\",\n      \"method\": \"Cell cycle synchronization; Western blotting; immunofluorescence; colocalization studies\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional context, single lab\",\n      \"pmids\": [\"16730707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UV irradiation induces p38 MAPK-mediated phosphorylation of Tbx2 at serine residues 336, 623, and 675; this phosphorylation increases Tbx2 protein levels, drives nuclear localization, and enhances Tbx2-mediated repression of the p21 promoter.\",\n      \"method\": \"In vitro kinase assays; site-directed mutagenesis; Western blotting; immunofluorescence; reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay with mutagenesis of specific phospho-sites and functional reporter validation\",\n      \"pmids\": [\"18025091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tbx2 specifically associates with active hypophosphorylated retinoblastoma protein (Rb1), but not with p107 or p130; this interaction maps to a domain carboxy-terminal to the T-box, enhances Tbx2 DNA binding and transcriptional repression, and modulates Tbx2 target gene selectivity including cell cycle control genes.\",\n      \"method\": \"Co-immunoprecipitation; domain mapping; microarray analysis; inducible dominant-negative Tbx2 with Rb1-interaction domain mutation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction mapping, domain mutagenesis, and genome-wide target analysis in a single study\",\n      \"pmids\": [\"20534814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Tbx20 directly attenuates BMP/Smad-dependent transcriptional activation of Tbx2 by binding Smad1 and Smad5 and sequestering them from Smad4, independently of Tbx20 DNA binding. A BMP/Smad-dependent Tbx2 enhancer confers AVC-restricted expression and Tbx20-dependent chamber suppression of Tbx2.\",\n      \"method\": \"Single and double knockout embryo analysis; identification of Tbx2 enhancer; transfection and localization studies; Smad binding assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis combined with biochemical interaction studies and enhancer identification\",\n      \"pmids\": [\"19661464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tbx2 and Tbx3 function redundantly to maintain AVC myocardium phenotype; ChIP-sequencing of Tbx3 reveals direct interaction with and repression of chamber myocardial genes; Tbx2/3 trigger atrioventricular cushion development through a regulatory feed-forward loop with Bmp2.\",\n      \"method\": \"Knockout and inducible overexpression mouse models; expression profiling; ChIP-sequencing\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with genetic knockout models, multiple orthogonal approaches\",\n      \"pmids\": [\"22130515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx2 directly binds to the Cdkn1a (p21) and Cdkn1b (p27) loci in vivo in lung mesenchyme (ChIP); loss of Tbx2 causes lung hypoplasia with increased p21/p27 expression, and combined deletion of Cdkn1a and Cdkn1b largely rescues the lung growth deficit of Tbx2-deficient mice.\",\n      \"method\": \"Conditional knockout mice; genetic rescue (double Cdkn1a/Cdkn1b knockout); ChIP; gene expression analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP demonstrates direct binding, genetic epistasis rescue confirms functional relevance\",\n      \"pmids\": [\"23341776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx2 directly represses Grem1 in the posterior limb mesenchyme (by binding T-box elements in the Grem1 locus), thereby terminating the Shh/Fgf4 signaling loop; Tbx2-deficient hindlimbs show prolonged Shh/Fgf4 signaling and digit duplication, while overexpression causes premature loop termination.\",\n      \"method\": \"Tbx2 conditional knockout and overexpression in mice; ChIP; in vivo reporter assays; digit phenotype analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding shown by ChIP, confirmed by reciprocal loss- and gain-of-function phenotypes\",\n      \"pmids\": [\"23633963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tbx2 and Tbx3 act downstream of epithelially derived Shh signaling in lung mesenchyme to maintain canonical Wnt signaling, in part by directly repressing the Wnt antagonists Frzb and Shisa3 (shown by ChIP), and thereby promote mesenchymal proliferation.\",\n      \"method\": \"Conditional double mutant mice; genetic rescue; ChIP; expression profiling\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding of Tbx2/3 to target gene loci by ChIP, combined with genetic rescue experiments\",\n      \"pmids\": [\"27720610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genetic lineage tracing using Tbx2Cre shows that Tbx2+ primary myocardium of the AVC gives rise to the atrioventricular node; in Tbx2-deficient embryos, the AVC prematurely differentiates to chamber myocardium and proliferates at increased rates, demonstrating that Tbx2 temporally suppresses both differentiation and proliferation of primary myocardial cells.\",\n      \"method\": \"Genetic lineage tracing (Tbx2Cre knock-in); Tbx2-deficient embryo analysis; proliferation and marker analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct lineage tracing with functional loss-of-function validation\",\n      \"pmids\": [\"19423846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Myocardium-specific inactivation of Tbx2 leads to formation of fast-conducting accessory pathways (Wolff-Parkinson-White-like), malformation of the annulus fibrosus, and ventricular preexcitation; the accessory pathways ectopically express fast-conduction proteins Cx40, Cx43, and Scn5a, establishing that Tbx2 is required for proper atrioventricular myocardial patterning to prevent accessory pathway formation.\",\n      \"method\": \"Conditional myocardium-specific Tbx2 knockout; electrophysiological recordings; immunohistochemistry for gap junction proteins\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout with defined molecular and electrophysiological phenotype\",\n      \"pmids\": [\"21266775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tbx2 represses Connexin43 (Cx43) promoter activity by directly binding two TCACAC T-box consensus sites in the Cx43 promoter; antisense-mediated downregulation of Tbx2 in osteosarcoma cells de-represses endogenous Cx43 expression and increases functional gap junction communication.\",\n      \"method\": \"In vitro binding assays; cotransfection reporter assays; promoter mutagenesis; antisense stable transfection; transgenic mouse analysis\",\n      \"journal\": \"Calcified tissue international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding, mutagenesis, functional reporter assays, and endogenous gene expression validated in stable cell lines\",\n      \"pmids\": [\"15354864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TBX2 directly represses E-cadherin transcription (shown by ChIP and reporter assays) and induces epithelial-mesenchymal transition (EMT); ectopic TBX2 in normal mammary epithelial cells causes loss of epithelial markers and gain of mesenchymal markers, increased invasion, and lung metastasis in xenografts.\",\n      \"method\": \"Ectopic TBX2 expression; TBX2 knockdown; ChIP; reporter assays; xenograft mouse model; EMT marker analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates direct E-cadherin promoter binding; in vivo xenograft validates functional consequence\",\n      \"pmids\": [\"22844464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TBX2 interacts with Heterochromatin Protein 1 (HP1) through a conserved HP1-binding motif in its N-terminus; this recruits KAP1, DNMT3B, and histone methyltransferase complex components (G9A, EZH2, SUZ12) to EGR1-targeted promoters (e.g., NDRG1), establishing H3K9me3 repressive marks. Mutation of the TBX2 HP1-binding domain abrogates this interaction and relieves target gene repression.\",\n      \"method\": \"Co-immunoprecipitation; HP1-binding motif mutagenesis; ChIP for H3K9me3 and complex components; siRNA knockdown; reporter assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical and chromatin assays with mutagenesis validation in a single study\",\n      \"pmids\": [\"31253870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TBX2 directly represses the PTEN tumor suppressor promoter by binding it and recruiting HDAC1 in rhabdomyosarcoma and skeletal muscle cells; TBX2 depletion upregulates PTEN and reduces phospho-AKT, placing TBX2 in the PTEN/PI3K/AKT pathway.\",\n      \"method\": \"ChIP; HDAC1 recruitment assay; TBX2 knockdown/dominant-negative; Western blotting for phospho-AKT; xenograft tumor assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct ChIP evidence for promoter binding and co-repressor recruitment, functional validation in vivo\",\n      \"pmids\": [\"26686089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TBX2 interacts with myogenic regulatory factors MyoD and myogenin and inhibits their transcriptional activity; TBX2 recruits HDAC1 to muscle-specific gene promoters to repress expression, blocking differentiation in rhabdomyosarcoma cells.\",\n      \"method\": \"Co-immunoprecipitation of TBX2 with MyoD/myogenin; ChIP for HDAC1; gene expression analysis; TBX2 depletion/dominant-negative; xenograft assay\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal protein interaction, ChIP, and functional validation with in vivo xenograft\",\n      \"pmids\": [\"24470334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PML tumor suppressor directly represses TBX2 transcription through a p130/E2F4 repressor complex at the TBX2 promoter in senescence; conversely, elevated TBX2 antagonizes PML pro-senescence function through direct protein-protein interaction with PML, establishing an autoregulatory loop.\",\n      \"method\": \"Gene expression profiling; ChIP; promoter reporter assays; PML-TBX2 co-immunoprecipitation; TBX2 knockdown/depletion\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP, protein-protein interaction by co-IP, functional epistasis\",\n      \"pmids\": [\"22002537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Retinoic acid (RA) directly downregulates Tbx2 expression through a functional retinoic acid response element (RARE) in the Tbx2 promoter; Tbx2 in turn activates Tgfb2 expression in the outflow tract, and the Tbx2-Tgfβ2 cascade is required for epithelial-mesenchymal transition in outflow tract cushion development.\",\n      \"method\": \"Identification of RARE in Tbx2 promoter; RA treatment of mouse embryos; Tgfb2 rescue in organ culture; gene expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RARE identified and functionally validated, Tgfb2 induction by Tbx2 in culture, rescue experiment\",\n      \"pmids\": [\"22186728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TGF-β1 signaling upregulates TBX3, which then transcriptionally represses TBX2 expression, and this TBX2 downregulation mediates part of the anti-proliferative function of the TGF-β1-TBX3 axis.\",\n      \"method\": \"TGF-β1 treatment; TBX3 knockdown/overexpression; TBX2 promoter reporter assays; proliferation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway established by knockdown and reporter assays, single lab\",\n      \"pmids\": [\"25371204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TBX2 co-represses CST6 (Cystatin 6) together with EGR1; this relieves Legumain (LGMN) from inhibition, sustaining breast cancer proliferation. CST6 expression in TBX2-expressing breast cancer cells induces apoptosis specifically through its LGMN-inhibitory domain.\",\n      \"method\": \"TBX2 knockdown; ectopic CST6 expression; CST6 domain mutagenesis; siRNA knockdown of LGMN; LGMN activity assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway validated by domain mutagenesis and enzymatic assays\",\n      \"pmids\": [\"24742492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBX2 acts in trans to promote transcription of the canonical WNT3A promoter in prostate cancer cells; blocking endogenous TBX2 reduces WNT3A expression, invasion, and bone metastasis, and genetic rescue of WNT3A partially restores TBX2-induced metastatic capability.\",\n      \"method\": \"Dominant-negative TBX2 construct; WNT3A promoter reporter assays; xenograft and intratibial mouse models; WNT3A rescue experiment; WNT3A-neutralizing antibodies\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter activation assay combined with in vivo genetic rescue, single study\",\n      \"pmids\": [\"28108510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tbx2 is a master regulator of inner vs. outer hair cell (IHC vs. OHC) fate in the cochlea: ablation of Tbx2 in embryonic IHCs causes complete transdifferentiation into OHCs; ectopic Tbx2 in OHCs causes their transdifferentiation into IHCs. Tbx2 is epistatic to Insm1: in the absence of both, only OHCs form, indicating TBX2 is necessary for INSM1-deficient OHC-to-IHC transdifferentiation.\",\n      \"method\": \"Conditional knockout (hair cell-specific Cre); ectopic overexpression in OHCs; epistasis double knockout; marker analysis for IHC/OHC identity\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal loss- and gain-of-function with genetic epistasis, multiple orthogonal approaches\",\n      \"pmids\": [\"35508658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TBX2 specifies the inner compartment (IHCs and inner supporting cells) of the cochlear sensory epithelium; conditional deletion converts IHCs to OHCs (repressing IHC genes, inducing OHC genes including Ikzf2), and misexpression converts OHCs to IHCs. Coupled with transient Atoh1, Tbx2 can reprogram non-sensory supporting cells into IHC-like cells.\",\n      \"method\": \"Conditional deletion (hair cell- and progenitor-specific Cre); conditional misexpression; transdifferentiation/reprogramming assays; IHC/OHC marker profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary loss- and gain-of-function approaches with molecular characterization\",\n      \"pmids\": [\"36494345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TBX2 acts downstream of otocyst Tbx2/Tbx3-mediated repression of FGF signaling to restrict neurogenesis to the anterior-ventral otocyst; conditional Tbx2 ablation from the otocyst causes cochlear hypoplasia and posterior-ventral expansion of the neurogenic domain.\",\n      \"method\": \"Conditional knockout (otocyst-specific); expression analyses; FGF signaling readouts\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined molecular phenotype, single study\",\n      \"pmids\": [\"33795231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TBX2 p.R20Q and p.R305H variants identified in patients with a DiGeorge-like syndrome show reduced transcriptional repressor activity and reduced protein levels in vitro; heterologous overexpression in Drosophila demonstrates both variants are partial loss-of-function alleles.\",\n      \"method\": \"In vitro transcriptional repression assays; protein level analysis; Drosophila overexpression assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in two systems (human cells and Drosophila), single study\",\n      \"pmids\": [\"29726930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx2 and Msx1 can physically interact in mouse C3H10T1/2 cells; Tbx2 represses Bmp4 expression in dental mesenchyme, and reducing Tbx2 dosage (Msx1-/-;Tbx2+/- compound mutants) partially rescues the Msx1-/- bud-stage arrest and restores mesenchymal Bmp4 expression.\",\n      \"method\": \"Co-immunoprecipitation of Tbx2 and Msx1; Tbx2 knockdown in C3H10T1/2 cells; Bmp4 expression analysis; genetic compound mutant rescue\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction demonstrated by co-IP, genetic epistasis rescue, and molecular phenotype\",\n      \"pmids\": [\"23720046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TBX2 and TBX3 act downstream of canonical WNT signaling in the ureteric mesenchyme; ChIP reveals TBX2/TBX3 directly repress Dkk2, Shisa2 (WNT antagonists), Bmper (BMP antagonist), and Cxcl12; loss of TBX2/TBX3 disrupts Foxf1 and BMP4 signaling, reducing smooth muscle cell differentiation.\",\n      \"method\": \"Conditional double knockout mice; ChIP; transcriptional profiling; smooth muscle differentiation analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct chromatin binding by ChIP combined with conditional knockout and pathway analysis\",\n      \"pmids\": [\"30478225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TBX2 interacts with HPV16 minor capsid protein L2, confirmed by co-immunoprecipitation and immunofluorescence; TBX2 (and TBX3) repress transcription from the HPV long control region (LCR) in reporter assays, and this repression is enhanced by L2; TBX2 binding to the HPV LCR was confirmed by ChIP.\",\n      \"method\": \"Yeast two-hybrid screening; co-immunoprecipitation; immunofluorescence; promoter reporter assays; ChIP\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — interaction confirmed by co-IP and ChIP, functional reporter assay, single study\",\n      \"pmids\": [\"23388722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TBX2 is a constituent of the core regulatory circuitry in neuroblastoma; TBX2 drives proliferation through activation of FOXM1 target genes that are normally repressed by the p21-DREAM complex; combined TBX2/MYCN knockdown enforces cell growth arrest, indicating TBX2 enhances MYCN-sustained FOXM1 target activation.\",\n      \"method\": \"Epigenomic super-enhancer analysis; TBX2/MYCN knockdown; cell proliferation assays; gene expression profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional epistasis between TBX2 and MYCN with defined transcriptional mechanism, single study\",\n      \"pmids\": [\"30451831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TBX2 binds the promoter of miR-200c-3p and represses its expression; repression of miR-200c-3p increases SOX2 and N-MYC levels; this TBX2/miR-200c-3p/SOX2/N-MYC axis promotes neuroendocrine prostate cancer transdifferentiation both intracellularly and via exosome-mediated intercellular signaling.\",\n      \"method\": \"Promoter binding assay; miR profiling; rescue with miR-200c-3p re-expression; exosome co-culture experiments\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding, pathway rescue with miR-200c-3p, and exosome mechanism, single study\",\n      \"pmids\": [\"34638504\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TBX2 is a T-box transcription factor that functions primarily as a transcriptional repressor: it directly binds variant T-box elements in target gene promoters (including p14ARF, p21WAF1, PTEN, E-cadherin, Grem1, Cdkn1a/b, Cx40, Cx43, ANF/Nppa) through its T-box DNA-binding domain and recruits corepressors (HDAC1, HP1/KAP1/EZH2/G9A complex) to silence these loci, thereby suppressing cellular senescence, maintaining progenitor/non-chamber cell identity in the heart AVC, driving proliferation in multiple tissues, and inducing EMT in cancer; its activity is regulated by p38 MAPK phosphorylation (serine 336/623/675), cell-cycle-dependent protein accumulation, interaction with Rb1 (which enhances DNA binding), upstream transcriptional activation by Mitf and BMP2/Smad signaling, and repression by Tbx20 (via Smad sequestration), PML/p130/E2F4, and TGF-β1/TBX3 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TBX2 is a T-box transcription factor that functions as a transcriptional repressor to control cell proliferation, differentiation, and tissue patterning across multiple organ systems. It binds variant T-box elements as a monomer through its T-box DNA-binding domain and recruits corepressor complexes—including HDAC1 and an HP1/KAP1/EZH2/G9A chromatin-silencing module—to establish repressive histone marks (H3K9me3) at target promoters such as p14ARF, p21WAF1, PTEN, E-cadherin, Cx40/Cx43, and Grem1, thereby suppressing senescence, blocking differentiation, and promoting proliferation [PMID:11062467, PMID:14996726, PMID:31253870, PMID:26686089]. In the heart, TBX2 maintains atrioventricular canal identity by repressing chamber-specific genes, and its loss causes accessory pathway formation and ventricular preexcitation; in the cochlea, TBX2 is the master determinant of inner hair cell versus outer hair cell fate, with its deletion or ectopic expression sufficient to switch cell identity [PMID:15042700, PMID:21266775, PMID:35508658]. TBX2 activity is regulated by BMP2/Smad signaling, Mitf-dependent transcription, p38 MAPK phosphorylation, interaction with hypophosphorylated Rb1, and antagonism by Tbx20-mediated Smad sequestration and PML/p130/E2F4-dependent transcriptional repression of the TBX2 locus [PMID:11087629, PMID:18025091, PMID:20534814, PMID:19661464, PMID:22002537]. Partial loss-of-function TBX2 variants (R20Q, R305H) have been identified in patients with a DiGeorge-like syndrome [PMID:29726930].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing TBX2 as a transcriptional repressor: TBX2 was shown to directly bind melanocyte promoter elements (MSEu/MSEi) and repress target gene (TRP-1) transcription, demonstrating that a T-box family member could function as a repressor rather than an activator.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis, and cotransfection reporter assays in melanocyte/melanoma cells\",\n      \"pmids\": [\"9710594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No corepressor mechanism identified\", \"Repression domain not yet mapped\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linking TBX2 repression to senescence bypass and cancer: TBX2 was identified as an immortalizing factor that represses the p19ARF/p14ARF locus, explaining how overexpression could bypass oncogene-induced senescence—a central question for its oncogenic role.\",\n      \"evidence\": \"Genetic senescence bypass screen in Bmi1-deficient MEFs; promoter repression assays; binding to a variant T-site in the ARF promoter confirmed by mutagenesis\",\n      \"pmids\": [\"11062467\", \"12000749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin mechanism of repression at the ARF locus not determined\", \"In vivo tumor suppressor pathway bypass not yet shown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defining upstream regulators: Mitf and BMP2 signaling were established as direct transcriptional activators of TBX2, placing it within defined developmental and lineage-specific signaling cascades in melanocytes and cardiogenesis.\",\n      \"evidence\": \"Mitf binding to E-box in TBX2 promoter by EMSA with mutagenesis; BMP2 bead implantation in chick embryos and analysis of bmp2-null mouse embryos\",\n      \"pmids\": [\"10770922\", \"11087629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Smad-binding element in Tbx2 enhancer not yet identified\", \"Relative contribution of Mitf vs. BMP2 in melanocytes unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defining TBX2's cardiac patterning role: TBX2 cooperates with Nkx2.5 to repress ANF in atrioventricular canal myocardium, and domain analysis revealed both N-terminal and C-terminal repression domains, establishing the structural basis for context-dependent repression.\",\n      \"evidence\": \"Transgenic and in vivo mutagenesis of TBE/NKE elements; GAL4-deletion analysis of repression domains\",\n      \"pmids\": [\"12023302\", \"11867218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor identity for cardiac targets unknown\", \"Crystal structure of TBX2 repression domains not available\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying HDAC1 as a TBX2-recruited corepressor and expanding target gene repertoire: TBX2 directly binds p21WAF1 and Cx43 promoters and recruits HDAC1 to mediate repression, providing the first chromatin-modifying mechanism for TBX2-dependent silencing.\",\n      \"evidence\": \"ChIP for TBX2 and HDAC1 at the p21 promoter; siRNA knockdown; in vitro binding and mutagenesis of Cx43 T-box sites\",\n      \"pmids\": [\"14996726\", \"15781639\", \"15354864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC1 recruitment is universal across all TBX2 targets not tested\", \"Structural basis of TBX2-HDAC1 interaction unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"In vivo requirement for TBX2 in cardiac chamber patterning: Tbx2-null and Tbx2-overexpressing mice demonstrated that TBX2 is both necessary and sufficient to suppress chamber myocardium gene expression in the AVC, establishing its role as a binary cell-fate switch in heart morphogenesis.\",\n      \"evidence\": \"Targeted Tbx2 knockout and transgenic overexpression in mice with marker gene analysis\",\n      \"pmids\": [\"15042700\", \"15459098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy with Tbx3 not yet quantified\", \"Direct chromatin targets in AVC not genome-wide mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Post-translational regulation resolved: p38 MAPK phosphorylates TBX2 at S336/S623/S675 upon UV stress, stabilizing the protein and enhancing nuclear accumulation and p21 repressor activity—explaining how stress signals modulate TBX2 function.\",\n      \"evidence\": \"In vitro kinase assays; phospho-site mutagenesis; immunofluorescence; reporter assays\",\n      \"pmids\": [\"18025091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other kinases that target TBX2 not surveyed\", \"Phosphorylation effects on non-p21 targets not examined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Tbx20 restricts Tbx2 expression by a non-canonical mechanism: Tbx20 sequesters Smad1/5 away from Smad4, attenuating BMP-dependent activation of the Tbx2 AVC enhancer—resolving how chamber myocardium excludes Tbx2.\",\n      \"evidence\": \"Single and double knockout embryos; identification of BMP/Smad-dependent Tbx2 enhancer; Smad co-immunoprecipitation\",\n      \"pmids\": [\"19661464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Tbx20 regulation of Tbx2 operates in non-cardiac tissues unknown\", \"Direct Smad4-enhancer binding not shown by ChIP\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Rb1 interaction enhances TBX2 function: TBX2 specifically binds hypophosphorylated Rb1 (not p107/p130) via a C-terminal domain, augmenting DNA binding and expanding target gene selectivity, linking TBX2 repression to the cell-cycle machinery.\",\n      \"evidence\": \"Co-immunoprecipitation; domain mapping; microarray with inducible dominant-negative TBX2 carrying Rb1-interaction domain mutation\",\n      \"pmids\": [\"20534814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TBX2-Rb1 interaction not resolved\", \"Whether Rb1 is required for TBX2 function at all targets not determined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Functional consequences of cardiac Tbx2 loss defined at the electrophysiological level: myocardium-specific Tbx2 deletion causes accessory pathway formation (Wolff-Parkinson-White-like phenotype) with ectopic Cx40/Cx43/Scn5a expression, establishing TBX2 as essential for annulus fibrosus integrity and prevention of ventricular preexcitation.\",\n      \"evidence\": \"Conditional myocardium-specific knockout; electrophysiological recordings; immunohistochemistry\",\n      \"pmids\": [\"21266775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether human WPW cases involve TBX2 mutations not established\", \"Relative contribution of Cx40 vs. Cx43 derepression to accessory pathway conduction not parsed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"PML-TBX2 autoregulatory loop in senescence: PML represses TBX2 transcription via a p130/E2F4 complex, while TBX2 protein antagonizes PML's pro-senescence function through direct binding, establishing a feedback circuit governing cellular senescence.\",\n      \"evidence\": \"ChIP at TBX2 promoter; co-immunoprecipitation of PML-TBX2; knockdown experiments\",\n      \"pmids\": [\"22002537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of PML-TBX2 loop in tumor suppression not tested\", \"Whether TBX2 disrupts PML nuclear bodies not examined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"TBX2 controls organ growth by direct repression of CDK inhibitors: ChIP demonstrated TBX2 occupancy at Cdkn1a/Cdkn1b loci in lung mesenchyme, and genetic deletion of both CDK inhibitors rescued lung hypoplasia of Tbx2-null mice, proving these are the critical proliferation targets.\",\n      \"evidence\": \"Conditional knockout; double Cdkn1a/Cdkn1b genetic rescue; ChIP in lung tissue\",\n      \"pmids\": [\"23341776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional Tbx2 targets contribute to lung growth not excluded\", \"Tbx2 targets in lung epithelium not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"TBX2 terminates the Shh/Fgf signaling loop in limb development: direct repression of Grem1 by TBX2 in posterior limb mesenchyme times the cessation of digit-forming signals, with loss causing polydactyly and gain causing premature loop termination.\",\n      \"evidence\": \"Conditional Tbx2 knockout and overexpression in mouse limbs; ChIP at Grem1 locus; digit phenotype analysis\",\n      \"pmids\": [\"23633963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TBX2 and TBX3 have distinct Grem1-regulatory roles not resolved\", \"Mechanism by which TBX2 selectively targets posterior mesenchyme unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A second corepressor mechanism elucidated: TBX2 recruits the HP1/KAP1/G9A/EZH2 complex via an N-terminal HP1-binding motif to establish H3K9me3 at target promoters, revealing a heterochromatin-based silencing pathway distinct from HDAC1 recruitment.\",\n      \"evidence\": \"Co-immunoprecipitation; HP1-binding motif mutagenesis; ChIP for H3K9me3 and complex components; siRNA knockdown\",\n      \"pmids\": [\"31253870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which targets use HP1 versus HDAC1 pathway not globally defined\", \"Whether both pathways operate simultaneously at the same locus unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"TBX2 identified as the master binary switch for cochlear hair cell fate: ablation converts inner hair cells to outer hair cells and ectopic expression converts outer to inner, demonstrating sufficiency and necessity for inner hair cell identity—a previously unresolved question in auditory biology.\",\n      \"evidence\": \"Conditional knockout and ectopic expression in hair cells; epistasis with Insm1; IHC/OHC marker profiling\",\n      \"pmids\": [\"35508658\", \"36494345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets that mediate IHC specification not genome-wide identified\", \"Whether TBX2 maintains IHC identity in the adult cochlea not fully tested\", \"Therapeutic potential for hearing restoration via TBX2 manipulation not validated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) the genome-wide partitioning of HDAC1- versus HP1/EZH2-dependent repression across TBX2 target genes; (2) a structural model of TBX2 bound to DNA and corepressor complexes; (3) whether TBX2 functions as a transcriptional activator at select loci in vivo (as suggested for WNT3A and Tgfb2) or only indirectly; (4) the full repertoire of post-translational modifications beyond p38-mediated phosphorylation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal/cryo-EM structure of TBX2\", \"Genome-wide corepressor usage not mapped\", \"Activator function not confirmed by ChIP for activating marks\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 5, 6, 20, 21]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 7, 21, 22, 23]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 11]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 4, 10, 12, 15]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 3, 5, 7, 22, 23]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 9, 13, 16, 18, 30, 31, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 13, 17, 29, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NKX2-5\",\n      \"HDAC1\",\n      \"RB1\",\n      \"PML\",\n      \"CBX5\",\n      \"MSX1\",\n      \"MYOD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}